FDA Says “No” To Onexa

fda advisory FDA Says No To Onexa

It’s been touted as the first new prescription weight-loss pill in more than a decade. But, following a study, a FDA advisory panel, because of safety concerns, refused to back the pill called Onexa.  The panel said the pill could cause depression, memory loss and holds the potential for birth defects if millions of overweight or obese Americans use it.

Listen to the report here:

Comments

Leave a Reply

Please log in using one of these methods to post your comment:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From KYMX Mix 96

Get The App
Follow Us On Facebook

Listen Live